Breakfast with Ryan Huang, Emaad Akhtar and Audrey Siek (6am-9am)Breakfast with Ryan Huang, Emaad Akhtar and Audrey Siek (6am-9am)

Companies To Watch: The hot investment case of AstraZeneca

View descriptionShare

The medical industry has achieved a new clinical milestone. In what’s touted as a transformational shift in how we approach precision medicine, AstraZeneca released a new study, revealing how its experimental breast cancer pill delayed disease progression by over six months.

Join Dan Koh and Emaad Akhtar as they venture into the world of medicine, and analyze what AstraZeneca’s new discovery could mean for its business and cancer treatment moving forward. 

  • Facebook
  • X (Twitter)
  • WhatsApp
  • Email
  • Download

In 2 playlist(s)

  1. Breakfast with Ryan Huang, Emaad Akhtar and Audrey Siek

    5,295 clip(s)

  2. MONEY FM 89.3

    19,388 clip(s)

Breakfast with Ryan Huang, Emaad Akhtar and Audrey Siek (6am-9am)

Get a head start on your workday with Ryan Huang, Emaad Akhtar and Audrey Siek from 6 am to 9 am.   
Social links
Follow podcast
Recent clips
Browse 4,366 clip(s)